Recently we have reported the structure determination of lavendamycin (1), a novel antibiotic closely related to streptonigrin (2) in structure ( Fig. 1 ).1) In this paper we report the characterization of the producing culture, the fermentation conditions, the isolation of, and biological activity of 1.
In the course of screening actinomycetes for the production of agents inducing lysogenic Escherichia coli strain W 1709 (h)2) strain C-22,030 was isolated from a soil sample collected from Wadington, New
York. An antibiotic produced by strain C-22,030 inhibited Staphylococcus aureus FDA strain 209P but was less active aginst a derived S. aureus Bristol A9626, streptonigrin resistant strain. However, the antibiotic from strain C-22,030 chromatographed differently from streptonigrin on paper chromatography. The level of activity to induce E. coli strain W1709 was increased as a result of a media improvement and strain selection program. With further improvement activity against the Walker 256 intramuscular tumor3) in the rat was observed.
Taxonomic Description
An inoculum for Streptomyces lavendulae NRRL B-12304) and strain C-22,030 was prepared for comparative diagnostic studies according to a procedure described by GOTTLIEB.5) On solid media with abundant aerial mycelium both organisms exhibit pink to red sporulation.
The sporophore of strain C-22,030 is usually flexuous and spores are in chains that are predominantly loose spirals with hooks and loops. Spores formed on yeast extract agar6) were examined with electron microscopy and were found to have smooth surfaces. The dimensions of spores are 1.1 x 1.42 u. Growth characteristics of strain C-22,030 (Table 1 ) and S. lavendulae NRRL B-1230 (Table 2) New Brunswick, New Jersey) set at 210 rev/minute and describing a 5.1 cm circle, 4 ml was transferred to 500-ml Erlenmeyer flasks containing a production medium selected from studies for improved lavendamycin yield. This medium consisted of cornstarch 40 g, peanut meal 10 g, linseed meal 10 g and CaCO3 5 g made up to one liter with deionized water. The production culture was incubated at 27°C for seven days on the previously described shaker.
For production in a tank fermentor 200 ml of inoculum culture was transferred to a tank with 38 liters of medium consisting of glucose 30 g, safflower meal 30 g, peanut meal 10 g and CaCO3 5 g made up to one liter with tap water. The tank was agitated at 375 rev/minute, the air flow was 91 liters/ minute, the back pressure was 1 atm and the tank was incubated at 27°C for 170 hours. The same production medium was used for a tank fermentor (D-fermentor) with 3,000 liters of medium, which was inoculated with 23 liters of culture. The tank was agitated at 155 rev/minute, the air flow was 2,100 liters/minute the back pressure was 1 atm and the tank was incubated at 27°C for 170 hours.
Isolation of Lavendamycin
The whole broth from a D-fermentor, approximately 1,700 liters, was extracted at broth pH (7.5 - The minimum inhibitory concentration (MIC) of lavendamycin was determined with a standard 2-fold tube dilution procedure.
2) The results are shown in Table 3 along with testing of streptonigrin.
In general the inhibition pattern is similar with lavendamycin being less potent. The only exception is with the fungi Trichophyton ruhrum, T. mentagrophytes and Microsporum canis where lavendamycin is more potent.
Induction of Lysogenic Bacteria
Lavendamycin was tested for its ability to induce bacteriophage production in the lysogenic strain of Erchcrichia coli W1709 (h),)using the methods of PRICE, et al.12) The minimum inducing concentration of 0.003 ug/ml is comparable to that of streptonigrin : 0.008 ug/ml, thus indicating a dissociation between inducing activity and other biological properties in comparing the two antibiotics. Antitumor Effects
Tests for inhibition of P-388 leukemia in mice were performed using procedures previously reported.13) The line of P-388 used was received from Bristol Banyu Research Institute through the courtesy of Dr. H. KAWAGUCHI. This line is sensitive to bleomycin products and is designated P-388-J. Lavendamycin was slightly active both on a daily, qd 1->9, schedule and given as a single dose (Table 4) . In other tests, not shown, lavendamycin had no inhibitory effect on standard P-388 or L-1210 leukemias. Table 4 . Effect of lavendamycin of P-388-J leukemia (Exp. #6450). 
HPLC Analysis Systems
The HPLC apparatus consisted of a Waters Assoc. Model M-6000A Solvent Delivery System, a Waters Assoc. Model U6K injector with a 2 ml loop, a ,u-Porasil prepacked column (Waters Assoc., 3.9 mm ID :< 30 cm, 10 u particle size), a Schoeffel Model SF770 spectroflow monitor U V detector, and a Heath/Schlumberger strip chart recorder. The normal phase HPLC solvent system employed was dichloromethane -methanol -water -30 % aqueous ammonia, 80: 20: 1 : 1 (v/v), and resulted in the following separation factor: K'lavendamycin=l. Found: C 63.14, H 3.74, N 13.27
